/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Brightpath Biotherapeutics

Brightpath Biotherapeutics

Japan

The company develops cell therapies and antibodies for cancer treatment

Healthcare & Biotech

Brightpath Biotherapeutics, based in Japan, has 2 investors on file, among them DBJ Capital and Fast Track Initiative. Its site was last checked 6 Nov 2026: site answers.

brightpathbio.com

Investors

2 investors on file
InvestorEvidenceType
DBJ CapitalPortfolio pageVenture capital
Fast Track InitiativePortfolio pageVenture capital

More from DBJ Capital

103 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (19%), AI & Machine Learning (15%), Enterprise Software (12%).

CYBERDYNECYBERDYNE develops and provides medical and robotic services and produ…Kringle PharmaKringle Pharma is a late-stage regenerative medicine bioventure that c…Prism BiolabPrism Biolab develops new drugs using its PepMetics technologyRestore VisionRestore Vision develops a visual restoration gene therapySymBio PharmaceuticalsThe company develops and delivers new drugs to patients.

See DBJ Capital's full profile · Who invests alongside it

More from Fast Track Initiative

26 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (86%), Industrial & Manufacturing (4%), AI & Machine Learning (4%).

Global VascularGlobal Vascular develops and provides medical devices, including the B…Metagen TherapeuticsThe company develops and provides medical treatments and pharmaceutica…RegcellRegCell develops therapies to treat autoimmune diseases by restoring i…STORM Therapeutics LtdSTORM Therapeutics develops and evaluates RNA modifying enzyme inhibit…VarinosVarinos develops and implements genetic tests using genome technology

See Fast Track Initiative's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Brightpath Biotherapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when DBJ Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/brightpathbio.com/investors

# also
GET /v1/companies/brightpathbio.com
GET /v1/companies/brightpathbio.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing